Literature DB >> 15921234

Molecular and neurologic findings of peroxisome biogenesis disorders.

Nobuyuki Shimozawa1, Tomoko Nagase, Yasuhiko Takemoto, Michinori Funato, Naomi Kondo, Yasuyuki Suzuki.   

Abstract

Peroxisomal disorders, an expanding group of genetic disorders in humans, can be grouped into three categories: peroxisome biogenesis disorders, single peroxisomal enzyme deficiencies, and contiguous gene syndrome. At present, 13 complementation groups of peroxisome biogenesis disorders and their responsible genes have been identified, including our newly identified group with a PEX14 defect. We describe neuronal abnormalities related to deficiencies in peroxisomes and the phenotype-genotype relationship in peroxisome biogenesis disorders. We also identified 32 Japanese patients with peroxisome biogenesis disorders, subdivided into six complementation groups. Our institution acts as the only diagnostic center for studies on peroxisomal disorders in Japan.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921234     DOI: 10.1177/08830738050200041001

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  4 in total

1.  Novel PEX3 Gene Mutations Resulting in a Moderate Zellweger Spectrum Disorder.

Authors:  C Maxit; I Denzler; D Marchione; G Agosta; J Koster; R J A Wanders; S Ferdinandusse; H R Waterham
Journal:  JIMD Rep       Date:  2016-08-25

2.  A Drosophila model for the Zellweger spectrum of peroxisome biogenesis disorders.

Authors:  Fred D Mast; Jing Li; Maninder K Virk; Sarah C Hughes; Andrew J Simmonds; Richard A Rachubinski
Journal:  Dis Model Mech       Date:  2011-06-13       Impact factor: 5.758

Review 3.  Molecular and clinical aspects of peroxisomal diseases.

Authors:  N Shimozawa
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

4.  Yeast peroxisomes multiply by growth and division.

Authors:  Alison M Motley; Ewald H Hettema
Journal:  J Cell Biol       Date:  2007-07-23       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.